PVd
Showing 1 - 25 of 254
Pulmonary Vascular Disorder, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disorder
- +2 more
- Supplemental oxygen therapy
- Sham Oxygen therapy
-
Zurich, SwitzerlandUniversity Hospital Zürich
Oct 9, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
PAD - Peripheral Arterial Disease, PVD- Peripheral Vascular Disease Trial in Redwood City (Tennant Biomodulator-Pro™ Device)
Completed
- PAD - Peripheral Arterial Disease
- PVD- Peripheral Vascular Disease
- Tennant Biomodulator-Pro™ Device
-
Redwood City, CaliforniaStanford Advanced Wound Care Center
May 3, 2022
Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)
Withdrawn
- Relapsed or Refractory Multiple Myeloma
- (no location specified)
Jan 26, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation to sea level
-
Zurich, SwitzerlandUniversity Hospital Zurich
Aug 9, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Assessment without intervention at High altitude
- Relocation to sea level for 2 days
-
Zurich, SwitzerlandUniversity Hospital Zurich
Oct 2, 2023
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation from HA to LA
-
Zurich, SwitzerlandRespiratory Clinic, University Hospital of Zurich
Oct 17, 2023
Vulvar Pain, Vulvodynia Trial in Portland (Modified Technique, Traditional Technique)
Not yet recruiting
- Vulvar Pain
- Vulvodynia
- Modified Technique
- Traditional Technique
-
Portland, OregonOregon Health and Science University
Apr 18, 2022
Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD) Trial in Zhejiang (Spot stent system, Self-expanding
Recruiting
- Peripheral Vascular Disease (PVD)
- Peripheral Arterial Disease (PAD)
- Spot stent system
- Self-expanding peripheral stent system
-
Zhejiang, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Aug 17, 2022
Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,
Active, not recruiting
- Light Chain Deposition Disease
- Primary Systemic Amyloidosis
- pomalidomide
- +3 more
-
Denver, Colorado
- +4 more
Jan 20, 2023
Nutrition Aspect of Cancer, Diet Modification, Cancer of Colon Trial in Florence (Meat-based diet, Meat-based diet supplemented
Completed
- Nutrition Aspect of Cancer
- +2 more
- Meat-based diet
- +2 more
-
Florence, ItalyUnit of Clinical Nutrition, University Hospital of Careggi
Jul 29, 2021
Provoked Vestibulodynia Trial in Haifa (Shockwave treatment)
Completed
- Provoked Vestibulodynia
- Shockwave treatment
-
Haifa, Northern Region, IsraelRambam Healthcare Campus
Sep 3, 2020
Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- JNJ-68284528
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 17, 2023
Diabetic Retinopathy, Posterior Vitreous Detachment, Disease Progression Trial in Worldwide (ocriplasmin 0.0625mg, ocriplasmin
Terminated
- Diabetic Retinopathy
- +2 more
- ocriplasmin 0.0625mg
- +2 more
-
Phoenix, Arizona
- +37 more
Dec 8, 2020
Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cells
- +8 more
-
Freiburg, Baden-Württemberg, Germany
- +31 more
Jan 5, 2023
Subtypes of Provoked Vestibulodynia
Completed
- Provoked Localized Vulvodynia
- Topical hormonal cream (estrogen)
- +2 more
-
Jerusalem, IsraelRamat Eshkol Women health center, Clalit health Services
Apr 6, 2022
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)
Recruiting
- Relapsed or Refractory Multiple Myeloma
- Teclistamab
- +4 more
-
Berkeley, California
- +188 more
Jan 27, 2023
Vulvodynia, Vestibulodynia Trial in Oslo (Somatocognitive physiotherapy, Treatment as usual)
Recruiting
- Vulvodynia
- Vestibulodynia
- Somatocognitive physiotherapy
- Treatment as usual
-
Oslo, NorwayOslo Metropolitan University
Sep 20, 2022
Peripheral Artery Disease, PAD, Claudication Trial in New York (Stealth 360°® OAS)
Completed
- Peripheral Artery Disease
- +4 more
- Stealth 360°® OAS
-
New York, New YorkNYU School of Medicine
Jan 30, 2020
Posterior Vitreous Detachment Trial in Khon Kaen (Wide-field optical coherence tomography (Optovue®))
Recruiting
- Posterior Vitreous Detachment
- Wide-field optical coherence tomography (Optovue®)
-
Khon Kaen, ThailandKhon Kaen University
Sep 2, 2021
Posterior Vitreous Detachment Trial in Khon Kaen (Wide-field optical coherence tomography)
Not yet recruiting
- Posterior Vitreous Detachment
- Wide-field optical coherence tomography
-
Khon Kaen, ThailandKhon Kaen University
Jun 29, 2021
Pulmonary Hypertension in Left Heart Disease
Not yet recruiting
- Pulmonary Hypertension
- +2 more
- Transthoracic Echocardiography (TTE)
- Lung ultrasound
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 29, 2023
Surgical Wound Trial in United States (Cardiva Medical VASCADE VCS)
Completed
- Surgical Wound
- Cardiva Medical VASCADE VCS
-
Houma, Louisiana
- +4 more
Jan 6, 2020